DR. ARTHUR KAVANAUGH, M.D.
Osteopathic Medicine at Campus Point Dr, La Jolla, CA

License number
California C50307
Category
Osteopathic Medicine
Type
Allergy & Immunology
License number
California C50307
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California C50307
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address 2
9350 Campus Point Dr, La Jolla, CA 92037
2957 Fried Ave, San Diego, CA 92122
Phone
(858) 657-7044
(858) 657-7045 (Fax)

Organization information

See more information about ARTHUR KAVANAUGH at bizstanding.com

Arthur Kavanaugh MD

9350 Campus Pt Dr, La Jolla, CA 92037

Industry:
Allergist, Internist
Phone:
(858) 657-7044 (Phone)
Arthur Francis Kavanaugh

Professional information

Arthur Kavanaugh Photo 1

Dr. Arthur Kavanaugh, La Jolla CA - MD (Doctor of Medicine)

Specialties:
Rheumatology
Address:
Arthritis Center at UCSD
9350 Campus Point Dr STE B, La Jolla 92037
(858) 657-6110 (Phone)
9500 Gilman Dr, La Jolla 92093
(858) 534-2359 (Phone)
Procedures:
Joint Drainage, Myofascial Trigger Point Injection, Non-Spinal Nerve Blocks
Conditions:
Antiphospholipid Syndrome (APS), Arthritis, Bursitis, Carpal Tunnel Syndrome, Cryoglobulinemia, Dermatomyositis, Enthesopathy of Hip (incl. Trochanteric Bursitis), Fibromyalgia, Gout, Hammer Toe, Henoch–Schönlein Purpura (HSP), Hepatitis B - Immune Response, Immune Thrombocytopenic Purpura (ITP), Low Back Pain, Osteoarthritis, Osteoarthritis of Hand or Wrist, Osteoarthritis of Hip, Osteoarthritis of Knee, Osteoarthritis of Spine, Osteopenia, Osteoporosis, Patellofemoral Pain Syndrome or Knee Pain, Polymyalgia Rheumatica (PMR), Polymyositis, Reiter's Syndrome (Reactive Arthritis), Rheumatoid Arthritis, Sjögren's Syndrome, Spondylitis, Still's Disease, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Takayasu's Arteritis, Trigger Finger, Vasculitis, Wegener's Granulomatosis
Certifications:
Allergy & Immunology, 1989, Internal Medicine, 1987, Rheumatology, 2002
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Education:
Medical School
Saint Louis University School Of Medicine
Graduated: 1984
Baylor College Of Med
Graduated: 1985
Graduated: 1987
Southwestern University


Arthur Francis Kavanaugh Photo 2

Arthur Francis Kavanaugh, San Diego CA

Specialties:
Internal Medicine, Rheumatology, Allergy & Immunology
Work:
Va San Diego Healthcare System
3350 La Jolla Village Dr, San Diego, CA 92161 Urgentcare San Diego Thornton Hospital
9300 Campus Point Dr, La Jolla, CA 92037 University of California at San Diego
9500 Gilman Dr, La Jolla, CA 92093 UC San Diego Health System
4168 Front St, San Diego, CA 92103
Education:
Saint Louis University (1984)


Arthur F Kavanaugh Photo 3

Arthur F Kavanaugh, La Jolla CA

Specialties:
Rheumatologist
Address:
9350 Campus Point Dr, La Jolla, CA 92037
Education:
Saint Louis University, School of Medicine - Doctor of Medicine
Parkland Memorial Hospital - Fellowship - Rheumatology (Internal Medicine)
Baylor Clinic & Hospital - Residency - Allergy and Immunology
Baylor Clinic & Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine


Arthur Kavanaugh Photo 4

Uses And Compositions For Treatment Of Rheumatoid Arthritis

US Patent:
2008016, Jul 10, 2008
Filed:
Apr 10, 2007
Appl. No.:
11/786442
Inventors:
Hartmut Kupper - Mutterstadt, DE
Jeffrey D. Kent - Deerfield IL, US
Mary A. Cifaldi - Gurnee IL, US
John L. Perez - Doylestown PA, US
Gerd R. Burmester - Berlin, DE
Philip Mease - Seattle WA, US
Daniel J. Lovell - Cincinnati OH, US
Edward Keystone - Toronto, CA
Arthur Kavanaugh - San Diego CA, US
International Classification:
A61K 39/395, G01N 33/68, A61K 39/09, A61K 39/145, A61P 37/00, A61P 19/02
US Classification:
4241361, 4241581, 436 86, 514 12, 4241331, 4241421, 4242441, 4242091
Abstract:
The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNFα inhibitor, such as a human TNFα antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNFα inhibitor for treatment of rheumatoid arthritis in a subject.